TACE Plus Targeted Therapy Boosts Post-Transplant Liver Cancer Survival
In the relentless battle against hepatocellular carcinoma (HCC), particularly when it recurs after the critical intervention of liver transplantation (LT), new therapeutic strategies emerge as...